Efficacy and Safety of Ombitasvir/Paritaprevir/R and Dasabuvir plus /- Ribavirin in Hcv Genotype 1-Infected Patients with a History of Bleeding Disorders: Results from Phase 3 Trials
66Th Annual Meeting of the American-Association-For-The-Study-Of-Liver-Diseases (Aasld), Date: NOV 13-17, 2015, Location: San Francisco, CA, Sponsors: Amer Assoc Study Liver Dis
